In this study, we aimed to examine the association between serum CEA levels at different perioperative time points and CRC outcomes using a retrospective, multicenter longitudinal cohort and to determine the optimal timing for postoperative serum CEA measurement. The gene discussed is CEACAM5; the disease is colorectal carcinoma.